Filing Flows › Comparisons › ELAB vs ENSC
Pmgc Holdings vs Ensysce Biosciences: ELAB and ENSC compared
Pmgc Holdings is the larger company: $1.3M of revenue in its latest quarter (Q2 2026) against $1.2M for Ensysce Biosciences (Q2 2026). Ensysce Biosciences is more profitable, with an operating margin of -221.3% against -225.1%.
Where the money goes: ELAB and ENSC
Pmgc Holdings (ELAB) · Q2 2026
Pmgc Holdings, Q2 2026: revenue $1.3M, operating margin -225.1%, net loss $2.9M, operating cash flow −$2.0M. The chart follows the revenue to costs, profit and cash.
Ensysce Biosciences (ENSC) · Q2 2026
Ensysce Biosciences, Q2 2026: revenue $1.2M (-15% year over year), operating margin -221.3%, net loss $2.6M, operating cash flow −$2.0M. The chart follows the revenue to costs, profit and cash.
| Pmgc Holdings (ELAB) | Ensysce Biosciences (ENSC) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $1.3M | $1.2M |
| Revenue growth, Y/Y | — | -15% |
| Operating margin | -225.1% | -221.3% |
| Net earnings | −$2.9M | −$2.6M |
| Net margin | -225.1% | -220.8% |
| Operating cash flow | −$2.0M | −$2.0M |
Questions
Which is bigger, Pmgc Holdings or Ensysce Biosciences?
Pmgc Holdings is the larger company: $1.3M of revenue in its latest quarter (Q2 2026) against $1.2M for Ensysce Biosciences (Q2 2026).
Is Pmgc Holdings or Ensysce Biosciences growing faster?
Ensysce Biosciences is more profitable, with an operating margin of -221.3% against -225.1%.
More: Pmgc Holdings earnings · how Pmgc Holdings makes money · Ensysce Biosciences earnings · how Ensysce Biosciences makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 14, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.